13F
← All fund report cards

CBRE INVESTMENT MANAGEMENT LISTED REAL ASSETS LLC

13F equity value
$6.7B
Positions
96
Top 10 concentration
39.9%
Quarters / total new picks
32 / 223
13F equity value over time
$0M$4B$9B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = -0.88, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-1.9%
t-stat
-0.88
Quarterly win rate
47%
Annualized excess
-2.6%
$1 → follow vs universe
$1.72 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.07820180630: follow 1.04520180930: follow 1.10020181231: follow 1.15920190331: follow 1.18920190630: follow 1.07120190930: follow 1.11220191231: follow 0.75620200331: follow 0.87720200630: follow 0.82820200930: follow 0.98320201231: follow 1.02720210331: follow 1.04320210630: follow 1.19420210930: follow 1.21420211231: follow 1.22620220331: follow 1.27520220630: follow 1.14720220930: follow 1.18420221231: follow 1.16120230331: follow 1.12720230630: follow 1.09520230930: follow 1.19720231231: follow 1.35820240331: follow 1.45820240630: follow 1.43120240930: follow 1.41820241231: follow 1.42020250331: follow 1.46820250630: follow 1.49820250930: follow 1.69720251231: follow 1.718 0.70 1.47 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 96 · 2026 Q1

Ticker Value Weight QoQ
WELL $594M
8.8%
TRIM
EQIX $518M
7.7%
TRIM
PLD $289M
4.3%
HOLD
SPG $226M
3.3%
TRIM
XEL $206M
3.1%
ADD
AMT $192M
2.8%
ADD
PEG $178M
2.6%
ADD
PPL $176M
2.6%
ADD
WEC $159M
2.4%
ADD
VTR $155M
2.3%
ADD
EGP $146M
2.2%
ADD
VICI $146M
2.2%
TRIM
LNG $145M
2.1%
TRIM
BRX $142M
2.1%
TRIM
ATO $140M
2.1%
ADD
ETR $138M
2.1%
TRIM
FR $129M
1.9%
TRIM
IRM $126M
1.9%
TRIM
PCG $120M
1.8%
HOLD
CEG $116M
1.7%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.